Table 3.
Probiotic Group (n = 68) | Within group p value | Placebo Group (n = 68) | Within group p value | Interaction p value | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Mean ± SD | Mean ± SD | |||||||||
Baseline | Week 6 | Week 12 | Baseline | Week 6 | Week 12 | ITT | PP | |||
Renal profile | ||||||||||
Sodium (mmol/L)† | 138.5 ± 2.2 | 138.9 ± 2.7 | 138.1 ± 3.5 | 0.147 | 137.9 ± 2.5 | 138.8 ± 2.9 | 138.5 ± 3.1 | 0.167 | 0.235 | 0.280 |
Potassium (mmol/L) | 4.42 ± 0.30 | 4.42 ± 0.31 | 4.35 ± 0.31 | 0.060 | 4.40 ± 0.40 | 4.34 ± 0.36 | 4.37 ± 0.43 | 0.360 | 0.164 | 0.351 |
Urea (mmol/L) | 4.26 ± 1.29 | 4.03 ± 1.00 | 4.04 ± 1.04 | 0.086 | 4.03 ± 0.89 | 4.07 ± 1.10 | 4.24 ± 1.14 | 0.081 | <0.05 | 0.181 |
Creatinine (μmol/L) | 69.20 ± 17.36 | 70.87 ± 18.70 | 72.26 ± 19.73 | <0.05 | 72.10 ± 18.84 | 71.95 ± 18.60 | 75.17 ± 18.93 | <0.05 | 0.329 | 0.288 |
GFR (ml/min) | 74.45 ± 18.5 | 74.14 ± 16.94 | 73.07 ± 17.13 | 0.710 | 73.66 ± 13.38 | 73.91 ± 13.58 | 68.89 ± 13.55 | <0.05 | 0.147 | 0.197 |
Liver function tests | ||||||||||
Albumin (g/L) | 45.64 ± 3.22 | 45.38 ± 3.18 | 45.48 ± 2.97 | 0.551 | 45.51 ± 2.53 | 45.81 ± 2.05 | 45.94 ± 1.93 | 0.339 | 0.147 | 0.224 |
Total protein (g/L) | 74.24 ± 4.93 | 73.32 ± 5.14 | 73.03 ± 5.98 | 0.190 | 73.87 ± 3.73 | 72.33 ± 4.89 | 71.59 ± 5.19 | <0.05 | 0.695 | 0.534 |
Bilirubin (μmol/L)† | 9.77 ± 3.50 | 10.03 ± 3.59 | 10.09 ± 3.70 | 0.739 | 10.38 ± 3.92 | 10.27 ± 3.20 | 10.28 ± 3.20 | 0.996 | 0.260 | 0.845 |
ALT (U/L)† | 23.20 ± 9.65 | 22.38 ± 10.13 | 22.33 ± 10.02 | 0.199 | 32.53 ± 16.10 | 32.59 ± 16.78 | 33.27 ± 17.29 | 0.823 | 0.421 | 0.374 |
ALP (U/L) | 68.49 ± 23.19 | 68.28 ± 21.82 | 67.00 ± 21.77 | 0.209 | 73.42 ± 18.11 | 71.97 ± 18.57 | 71.29 ± 20.72 | 0.134 | 0.481 | 0.485 |
AST (U/L) | 26.84 ± 77.12 | 24.58 ± 6.64 | 25.71 ± 6.81 | 0.441 | 20.12 ± 4.68 | 20.26 ± 5.12 | 21.29 ± 6.30 | 0.275 | 0.490 | 0.495 |
† log transformed GLM ANOVA